Mirion Technologies, Inc. (MIR)
MIR Stock Price Chart
Explore Mirion Technologies, Inc. interactive price chart. Choose custom timeframes to analyze MIR price movements and trends.
MIR Company Profile
Discover essential business fundamentals and corporate details for Mirion Technologies, Inc. (MIR) to support your stock research and investment decisions.
Sector
Industrials
Industry
Industrial - Machinery
IPO Date
20 Aug 2020
Employees
2.80k
Website
https://www.mirion.comCEO
Thomas D. Logan
Description
Mirion Technologies, Inc., established in 2005 and formerly known as Global Monitoring Systems, Inc. until its name change in January 2006, is based in Atlanta, Georgia. The company specializes in providing a comprehensive suite of specialized solutions for radiation detection, measurement, analysis, and monitoring. Its operations span a wide international footprint, covering countries such as the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, the Netherlands, Estonia, and Japan. The business is organized into two distinct operating segments: Medical and Industrial. The Medical segment delivers critical solutions aimed at enhancing patient safety and treatment accuracy within healthcare environments. Offerings here include quality assurance and dosimetry tools for radiation oncology, specialized patient safety systems for diagnostic imaging and radiation therapy centers, and precision calibration and verification solutions for medical imaging and treatment accuracy. Furthermore, it supplies radionuclide therapy products, which encompass shielding, handling equipment, dedicated medical imaging furniture, and rehabilitation aids for nuclear medicine applications. This segment fundamentally supports advancements in medical diagnostics, cancer treatment, professional safety for practitioners, and patient recovery. Conversely, the Industrial segment addresses vital requirements in radiation safety, measurement, and analysis across non-medical industries. It furnishes clients with personal radiation detection devices, identification equipment, and advanced analytical instrumentation. Mirion's extensive product and solution portfolio includes a variety of items such as nuclear medicine preparations, personal dosimeters, contamination and clearance monitoring systems, and sophisticated reactor instrumentation and control equipment. They also provide both medical and industrial imaging systems along with their related accessories, in addition to specialized instruments for alpha spectroscopy, alpha/beta counting, and gamma spectroscopy detector systems. Supplementary offerings include electrical penetration components, cancer diagnostic tools, software solutions, and a range of other services. Mirion serves a broad and varied clientele across numerous sectors. This includes healthcare providers like hospitals, clinics, urgent care facilities, dental and veterinary offices, and specialized radiation treatment centers, as well as original equipment manufacturers (OEMs) for radiation therapy. Beyond healthcare, their customers extend to research laboratories, military organizations, governmental agencies, various industrial enterprises, power and utility companies, reactor design firms, and nuclear power plants (NPPs).
MIR Financial Timeline
Browse a chronological timeline of Mirion Technologies, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 28 Jul 2026
EPS estimate is $0.10, while revenue estimate is $269.60m.
Earnings released on 28 Apr 2026
EPS came in at $0.10 matching the estimated $0.10, while revenue for the quarter reached $257.60m , beating expectations by +5.24%.
Earnings released on 10 Feb 2026
EPS came in at $0.15 falling short of the estimated $0.16 by -6.25%, while revenue for the quarter reached $277.40m , missing expectations by -1.05%.
Earnings released on 28 Oct 2025
EPS came in at $0.12 surpassing the estimated $0.11 by +9.09%, while revenue for the quarter reached $223.10m , missing expectations by -20.65%.
Earnings released on 31 Jul 2025
EPS came in at $0.11 surpassing the estimated $0.10 by +10.00%, while revenue for the quarter reached $222.90m , beating expectations by +0.17%.
Earnings released on 29 Apr 2025
EPS came in at $0.10 matching the estimated $0.10, while revenue for the quarter reached $202.00m , missing expectations by -7.81%.
Earnings released on 11 Feb 2025
EPS came in at $0.17 surpassing the estimated $0.14 by +21.43%, while revenue for the quarter reached $254.30m , beating expectations by +3.79%.
Earnings released on 29 Oct 2024
EPS came in at $0.08 falling short of the estimated $0.11 by -27.27%, while revenue for the quarter reached $206.80m , missing expectations by -15.84%.
Earnings released on 1 Aug 2024
EPS came in at $0.10 surpassing the estimated $0.08 by +25.00%, while revenue for the quarter reached $207.10m , missing expectations by -1.74%.
Earnings released on 30 Apr 2024
EPS came in at $0.06 matching the estimated $0.06, while revenue for the quarter reached $192.60m , beating expectations by +0.65%.
Earnings released on 13 Feb 2024
EPS came in at $0.15 surpassing the estimated $0.14 by +7.14%, while revenue for the quarter reached $230.40m , beating expectations by +5.26%.
Earnings released on 1 Nov 2023
EPS came in at $0.05 matching the estimated $0.05, while revenue for the quarter reached $191.20m , beating expectations by +7.07%.
Earnings released on 2 Aug 2023
EPS came in at $0.08 surpassing the estimated $0.06 by +33.33%, while revenue for the quarter reached $197.20m , beating expectations by +3.52%.
Earnings released on 3 May 2023
EPS came in at $0.06 surpassing the estimated $0.05 by +20.00%, while revenue for the quarter reached $182.10m , beating expectations by +1.62%.
Earnings released on 14 Feb 2023
EPS came in at $0.11 falling short of the estimated $0.12 by -8.33%, while revenue for the quarter reached $217.90m , beating expectations by +8.52%.
Earnings released on 1 Nov 2022
EPS came in at $0.03 falling short of the estimated $0.06 by -50.00%, while revenue for the quarter reached $160.90m , beating expectations by +0.06%.
Earnings released on 29 Jul 2022
EPS came in at $0.13 surpassing the estimated $0.12 by +8.33%, while revenue for the quarter reached $175.80m , missing expectations by -2.94%.
Earnings released on 4 May 2022
EPS came in at $0.10 surpassing the estimated $0.09 by +11.11%, while revenue for the quarter reached $163.20m , beating expectations by +112.55m%.
Earnings released on 23 Feb 2022
EPS came in at -$0.56 falling short of the estimated $0.12 by -567.18%, while revenue for the quarter reached $177.80m .
Earnings released on 12 Nov 2021
EPS came in at -$3.02 , while revenue for the quarter reached $144.30m .
Earnings released on 13 Aug 2021
EPS came in at -$8.14 , while revenue for the quarter reached $180.00m .
MIR Stock Performance
Access detailed MIR performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
